AA
AMED

AQR Arbitrage’s Amedisys AMED Stock Holding History

AQR Arbitrage’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-690,911
Closed -$67.8M – 449
2025
Q2 		$67.8M Buy
690,911
+113,371
+20% +$10.7M 1.56% 12
2025
Q1 		$53.5M Buy
577,540
+105,575
+22% +$9.73M 1.26% 17
2024
Q4 		$42.8M Buy
471,965
+175,311
+59% +$16.1M 0.94% 23
2024
Q3 		$28.6M Sell
296,654
-103,696
-26% -$10.1M 0.62% 48
2024
Q2 		$36.8M Sell
400,350
-43,299
-10% -$4.02M 0.95% 22
2024
Q1 		$40.9M Buy
443,649
+91,634
+26% +$8.59M 1.43% 11
2023
Q4 		$33.4M Buy
352,015
+37,694
+12% +$3.52M 1.35% 10
2023
Q3 		$29.4M Buy
314,321
+252,405
+408% +$23.3M 1.32% 10
2023
Q2 		$5.66M Buy
+61,916
New +$5.08M 0.24% 101

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Arbitrage's AMED Position: Q3 2025 in Review

AQR Arbitrage sold out of Amedisys (AMED) in Q3 2025, closing a stake of 690,911 shares — an estimated $67.8M sold.

AQR Arbitrage first reported a position in AMED in Q2 2023 and held it in 9 quarters. The position peaked at $67.8M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • AQR Arbitrage reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • AQR Arbitrage sold 690,911 Amedisys shares in Q3 2025, an estimated $67.8M.
  • AQR Arbitrage first reported a position in Amedisys in Q2 2023 and held it in 9 quarters.
  • AQR Arbitrage's Amedisys position peaked at $67.8M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on AQR Arbitrage's 13F filing for Q3 2025, filed 14 Nov 2025.